Little is known about the possible risk associated with IF in people with DM and other comorbidities such as chronic kidney disease, chronic liver disease, and heart failure. However, it is known that T2DM patients on insulin or sulfonylureas are at an increased risk of hypoglycemia. The gene discussed is INS; the disease is type 2 diabetes mellitus.